Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Kappos, Ludwig; Edan, Gilles; Freedman, Mark S; Montalbán, Xavier; Hartung, Hans-Peter; Hemmer, Bernhard; Fox, Edward J; Barkhof, Frederik; Schippling, Sven; Schulze, Andrea; Pleimes, Dirk; Pohl, Christoph; Sandbrink, Rupert; Suarez, Gustavo; Wicklein, Eva-Maria; BENEFIT Study Group; Strasser-Fuchs, S; Berger, T; Vass, K; Sindic, C; Dubois, B; Dive, D; Delvaux, V; Debruyne, J; Metz, L; Rice, G; Kremenchutzky, M; Duquette, P; Lapierre, Y; Freedman, M; Traboulsee, A; O'Connor, P; Stourac, P; Talab...    »
 
Titel:
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial. 
Abstract:
To assess outcomes for patients treated with interferon beta-1b immediately after clinically isolated syndrome (CIS) or after a short delay.Participants in BENEFIT (Betaferon/Betaseron in Newly Emerging MS for Initial Treatment) were randomly assigned to receive interferon beta-1b (early treatment) or placebo (delayed treatment). After conversion to clinically definite multiple sclerosis (CDMS) or 2 years, patients on placebo could switch to interferon beta-1b or another treatment. Eleven years...    »
 
Zeitschriftentitel:
Neurology 
Jahr:
2016 
Band / Volume:
87 
Heft / Issue:
10 
Seitenangaben Beitrag:
978-87 
Sprache:
eng 
Print-ISSN:
0028-3878 
TUM Einrichtung:
Neurologische Klinik und Poliklinik